Center for Genetic Engineering and Biotechnology (CIGB) in Havana highlighted the results of Cuban interferons in the treatment of patients positive for the SARS-COV-2 coronavirus, which caused the COVID-19 pandemic.
Havana, February 5 (RHC)-- On Friday, the Center for Genetic Engineering and Biotechnology (CIGB) in Havana highlighted the results of Cuban interferons in the treatment of patients positive for the SARS-COV-2 coronavirus, which caused the COVID-19 pandemic.
During an event held at the National Hotel of Cuba it was said that "Interferon has been an adequate therapeutic alternative and the main antiviral of the National Action Protocol for COVID-19." At the event, founders and workers of the CIGB linked to the development of the product, the first of Cuban biotechnology and with four decades of use in the country, were present.
Marta Ayala Avila, director of the institution, recalled the history of biotechnology in the nation and the presence of Commander in Chief Fidel Castro Ruz in the achievements of the sector.
She expressed the commitment of its workers who after the experience of these years, have the challenge and commitment to continue offering health to the Cuban people.
Regarding the use of Heberon, HeberFERON and Nasalferon, Dr. Ricardo Pereda Gonzalez, coordinator of the clinical experts of the Ministry of Public Health (Minsap) for the confrontation of the pandemic, thanked the scientists on behalf of the medical community for having a product that remains as one of the fundamental tools in the treatment of COVID-19. "No doctor today doubts the value of Cuban interferons, used not only in intensive care units, but which also began to be applied at opportune moments so that patients did not reach more severe symptoms," he added. "The three formulations turned out to be indispensable in the face of the virus," he said, and also mentioned the benefits of Jusvinza, a peptide from CIGB with good results in the battle to beat the disease and save lives.
Pereda Gonzalez said that interferons are a therapeutic strength of Cuban medicine for the prevention of coronavirus and other respiratory diseases.
Ileana Morales Suárez, Director of Science and Technological Innovation of Minsap, acknowledged the integration achieved between the workers of the CIGB and the different institutions so that these drugs could reach the patients. The doctor also pondered the importance of interferons in the Protocol of Action based on scientific evidence and said that what has been learned in these months will go down in history. During the activity, the Men of Science Seal was awarded to a group of outstanding workers in 2021 for their work in the production of these drugs. (Source: ACN)
